Comparative study of iv esmolol,iv diltiazem, and iv lignocaine hydrochloride in attenuating pressure response to laryngoscopy and intubation - N/A: N/A

Government medical college haldwani0 个研究点开始时间: 2020年3月20日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients equal to or greater than 18 years and equal or lesser than 60 years of age;Patients weighing equal to or greater than 40kg and equal or lesser than 90 kgs of either sex and BMI equal to or greater than 18.5 and equal or lesser than 24.9 of either sex;Patients posted for elective Surgical Procedure belonging to ASA physical status –
•Grade I and II;Patients requiring general Anesthesia and Endotracheal Intubation.

•Patient / guardian refusal for consent;ASA grade III and IV;Emergency surgeries;Patients between age greater than 60 years and Age lesser than 18 years;Patients weighing greater than 90kg and lesser than 40kg and BMI lesser than 18.5 and greater than 24.9;Patients suspected to have difficult tracheal intubation;Patients on beta-blockers or calcium channel blockers;Patients with significant renal (serum creatinine greater than 1.5mg/dl) ,hepatic (serum total bilirubin greater than 1.2 mg/dl, serum total protein lesser than 6g/dl & greater than 8.5g/dl ,serum albumin lesser than 3.5g/dl & greater than 5g/dl , serum SGPT greater than 40u/l , serum SGOT greater than 56u/l) disease;Hypertensive patients systolic blood pressure greater than 160 mmHg and or diastolic blood pressure greater than 95 mmHg;Patients with chronic obstructive lung diseases especially bronchial asthma;Diabetic patients on treatment;Patients with significant heart disease like past history of angina or myocardial infarction , heart blocks , and congestive cardiac failure;Laryngoscopy and intubation exceeding 20 seconds

发起方

Government medical college haldwani